Night-Time Blood Pressure and Non-Dipper: What Does No Nocturnal Dip Mean?

The nocturnal fall in blood pressure is part of the daily rhythm. During sleep, sympathetic nervous activity decreases, the heart rate slows, vascular tone falls, and the kidneys excrete part of the sodium accumulated during the day. When one of these mechanisms fails - sleep is interrupted, the sympathetic system stays activated, the kidneys remove sodium less well, and autonomic regulation is disturbed - the nocturnal fall is smaller or disappears. The body then works under a higher pressure load around the clock, without a period of 'rest' for the vessels and heart.

The first large population study to show a link between the nocturnal fall and prognosis came from the Japanese town of Ohasama.

Note the size of the effect: a 20% higher risk for each 5% smaller fall is statistically significant but within the scale typical of other risk markers. It is an observational result - it shows that absence of a nocturnal dip accompanies a worse prognosis; it does not prove that it is the cause of deaths, or that correcting it will improve prognosis.

The level of pressure at night itself seems more important than the 'percentage fall'. In an analysis of more than 7,400 people from cohorts in several countries, night-time pressure predicted cardiovascular events independently of daytime pressure, whereas daytime pressure lost significance for some endpoints once night-time pressure was accounted for.

The conclusion from Boggia et al. is twofold. First, night-time pressure has independent prognostic value, which justifies ABPM. Second, the 'night/day ratio' may reflect disease rather than be its cause: people with an abnormal profile are older and sicker.

This is an important correction to the popular message that 'a non-dipper is dangerous'. The data are less clear-cut than headlines suggest: the strongest risk signal concerns the reverse profile (pressure higher at night than in the day) and high night-time pressure as such, while a small lack of dip alone (for example 7-9%) is not necessarily a significant risk factor.

A lack of nocturnal dip is not a disease but a sign with various causes. The best documented include: sleep-disordered breathing, chronic kidney disease, diabetes and autonomic neuropathy, obesity, excess salt in the diet (especially with salt sensitivity), older age, shift work and chronically short or interrupted sleep. In some people the cause is also taking medicines at an unfortunate time, and alcohol in the evening.

In practice this means that if ABPM reveals non-dipping, it makes sense to ask not only 'should I take my medicines in the evening' but also 'why is this so'. Snoring, daytime sleepiness, morning headaches and pauses in breathing at night are reasons to ask about sleep apnoea (our separate articles on sleep apnoea describe symptoms and diagnosis, and our entry on obstructive and central sleep apnoea gives in-depth knowledge). Similarly, in people with diabetes or kidney disease the nocturnal profile is an additional clue for the doctor.

Similar conclusions come from the long-term PAMELA study (541 people followed for 25 years): of people with a dipper profile at the start, 37.15% kept it at both subsequent examinations at 10 and 25 years, and a persistent non-dipper profile was found in only 5.7%; in the group with persistent non-dipping no greater organ damage was shown than in the others after adjustment for risk factors. In other words, a single ABPM recording is a 'snapshot' - one night, influenced by sleep quality in unusual conditions (a cuff that wakes you), body position, and the previous day.

Since the nocturnal fall matters, a natural question is: does taking antihypertensive drugs in the evening restore the dipper profile and improve prognosis? Two large trials answered, with opposite conclusions.

A current 2026 meta-analysis (5 studies, 42,075 patients) found no significant difference between morning and night-time dosing: RR 1.04 (95% CI 0.92-1.19) for major cardiovascular events, 0.99 (0.91-1.08) for death from any cause, and 0.95 (0.75-1.20) for stroke. The authors point out that the results agree with modern high-quality trials (TIME, BedMed) and contrast with older meta-analyses.

An honest summary of the dispute: Hygia showed a huge effect (HR 0.55), TIME no difference (HR 0.95), and independent confirmation carries weight when results differ this much. The Hygia trial has been the subject of methodological criticism, and the journal published an 'expression of concern' (noted in the PubMed record). The description of the TIME trial does not indicate that patients were selected by 24-hour profile, so it does not say directly whether evening dosing benefits people with proven non-dipping. The current state of knowledge: there is not enough evidence to recommend routinely moving medicines to bedtime to improve prognosis.

We write in detail about recognising and treating sleep apnoea in our articles on symptoms and diagnosis of sleep apnoea and in our knowledge-base entry on chronic kidney disease, and about the effect of sleep on the circulation in our entry on sleep and cardiovascular health. The common denominator is that the night-time rhythm of blood pressure can be positively influenced by improving sleep and treating its disorders.

Limitations. Most prognostic data come from observational cohorts, which do not prove causation; the size of the effect is moderate. The 24-hour profile is poorly reproducible and depends on sleep quality during the test, body position and the measurement method. The definitions of 'dippers' differ slightly between studies. Trials on treatment (Hygia, TIME) gave conflicting results and are not directly comparable methodologically. Results for people with chronic kidney disease come mainly from retrospective cohorts with high heterogeneity.

Lack of a nocturnal drop in blood pressure is a diagnostic clue, not a diagnosis. It is worth confirming, looking for the cause - especially sleep apnoea, kidney disease and sleep disorders - and taking care of good blood pressure control around the clock. There is currently no solid evidence that moving medicines to bedtime improves prognosis, so leave the decision about timing to your doctor and choose an hour you can keep consistently. The most valuable investments for night-time pressure are usually simple things: good sleep, less salt and alcohol in the evening, and treatment of sleep apnoea if present.